In neurodegenerative disorders, Alzheimer’s disease (AD) exhibits amyloid pathology-driven disruption of protein homeostasis, linked to reduced ELP3 expression and impaired tRNA modification [131]. The gene discussed is ELP3; the disease is Alzheimer disease.